• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Classification and mechanism of action of antiarrhythmic drugs.

作者信息

Scholz H

机构信息

University of Hamburg, Department of Pharmacology, Germany.

出版信息

Fundam Clin Pharmacol. 1994;8(5):385-90. doi: 10.1111/j.1472-8206.1994.tb00817.x.

DOI:10.1111/j.1472-8206.1994.tb00817.x
PMID:7875632
Abstract

The present paper reviews classification and mode of action of agents that suppress extrasystoles and tachyarrhythmias. These are classified according to their electrophysiological effects observed in isolated cardiac tissues in vitro (Vaughan Williams, 1989). Fast sodium channel blockers (class I) which reduce the upstroke velocity of the action potential are usually subclassified into three groups, class I A-C, according to their effect on the action potential duration. Beta-adrenergic antagonists (class II) exert their effects by antagonizing the electrophysiological effects of beta-adrenergic catecholamines. Class III antiarrhythmic agents (eg amiodarone) prolong the action potential and slow calcium channel blockers (class IV) suppress the calcium inward current and calcium-dependent action potentials. The classification of antiarrhythmic drugs is still under debate. This particularly applies to agents of class I and III. The effect of class I agents is frequency-dependent because the binding affinity of these drugs to the sodium channel is modulated by the state of the channel (modulated receptor hypothesis). Class I agents bind to the channel in the activated and inactivated state and dissociate from the channel in the rested state. This occurs at a drug-specific rate so that class I agents can be subclassified into only two groups, namely in those of the slow- and fast-recovery type respectively (time constant of reactivation greater or smaller than 1 s). Slow-recovery class I agents affect regular action potentials at normal heart rates which can more easily lead to a lengthening of the QRS duration in the ECG, to conduction disturbances and hence to pro-arrhythmic effects.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

相似文献

1
Classification and mechanism of action of antiarrhythmic drugs.
Fundam Clin Pharmacol. 1994;8(5):385-90. doi: 10.1111/j.1472-8206.1994.tb00817.x.
2
[Antiarrhythmic agents. Receptor hypothesis explains mechanisms of action].
Tidsskr Nor Laegeforen. 1991 Oct 30;111(26):3187-9.
3
[New aspects of the electrophysiologic effect of antiarrhythmic agents].[抗心律失常药物电生理效应的新方面]
Herz. 1990 Apr;15(2):61-9.
4
[Current classification of anti-arrhythmia agents].[抗心律失常药物的当前分类]
Z Kardiol. 2000;89 Suppl 3:62-7.
5
Therapeutic drug monitoring: antiarrhythmic drugs.治疗药物监测:抗心律失常药物
Br J Clin Pharmacol. 1998 Oct;46(4):307-19. doi: 10.1046/j.1365-2125.1998.t01-1-00768.x.
6
Antiarrhythmic agents and proarrhythmia.抗心律失常药物与致心律失常作用
Crit Care Med. 2000 Oct;28(10 Suppl):N158-64. doi: 10.1097/00003246-200010001-00008.
7
Classification of antiarrhythmic drugs.抗心律失常药物的分类。
J Clin Pharmacol. 1989 May;29(5):387-94. doi: 10.1002/j.1552-4604.1989.tb03350.x.
8
Classification of antiarrhythmic agents: electropharmacologic basis and clinical relevance.
Cardiovasc Clin. 1992;22(1):97-116.
9
[Vaughan Williams class IV antiarrhythmic drugs].[ Vaughan Williams Ⅳ类抗心律失常药物]
Nihon Rinsho. 1996 Aug;54(8):2132-7.
10
Symposium on the management of ventricular dysrhythmias. Antifibrillatory versus antiectopic therapy.室性心律失常管理研讨会。抗纤颤与抗异位治疗。
Am J Cardiol. 1984 Jul 30;54(2):7A-13A. doi: 10.1016/0002-9149(84)90811-7.

引用本文的文献

1
Synthesis and In Vivo Antiarrhythmic Activity Evaluation of Novel Scutellarein Analogues as Voltage-Gated Nav1.5 and Cav1.2 Channels Blockers.新型白杨素类似物的合成及其作为电压门控钠离子通道 Nav1.5 和钙离子通道 Cav1.2 阻滞剂的体内抗心律失常活性评价。
Molecules. 2023 Nov 3;28(21):7417. doi: 10.3390/molecules28217417.
2
Synthesis and Structure-Activity Relationships of a Series of Aporphine Derivatives with Antiarrhythmic Activities and Acute Toxicity.一系列具有抗心律失常活性和急性毒性的阿朴啡衍生物的合成及构效关系
Molecules. 2016 Nov 28;21(12):1555. doi: 10.3390/molecules21121555.
3
Adrenergic regulation of a key cardiac potassium channel can contribute to atrial fibrillation: evidence from an I Ks transgenic mouse.
关键心脏钾通道的肾上腺素能调节可导致心房颤动:来自 IKs 转基因小鼠的证据。
J Physiol. 2008 Jan 15;586(2):627-37. doi: 10.1113/jphysiol.2007.141333. Epub 2007 Nov 15.